Alzheimer's Association Welcomes FDA Clearance of First Blood Test for Use in Primary Care to Rule Out Alzheimer's-Related Amyloid Pathology
October 13, 2025
October 13, 2025
CHICAGO, Illinois, Oct. 13 [Category: Health Care] -- The Alzheimer's Association posted the following news release:
* * *
Alzheimer's Association Welcomes FDA Clearance of First Blood Test for Use in Primary Care to Rule Out Alzheimer's-Related Amyloid Pathology
Key Takeaways
* Rules out Alzheimer's disease pathology and aids in assessing other causes of cognitive decline.
* Provides a new accessible tool for t . . .
* * *
Alzheimer's Association Welcomes FDA Clearance of First Blood Test for Use in Primary Care to Rule Out Alzheimer's-Related Amyloid Pathology
Key Takeaways
* Rules out Alzheimer's disease pathology and aids in assessing other causes of cognitive decline.
* Provides a new accessible tool for t . . .